顺丰控股公告，控股股东深圳明德控股发展有限公司及其一致行动人深圳市玮顺企业管理有限公司保证 向公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。公司及董事会全体 成员保证信息披露的内容与信息披露义务人提供的信息一致。控股股东深圳明德控股发展有限公司已于 2025年9月17日将其持有的公司2亿股A股股份过户至持股计划在中国证券登记结算有限责任公司开立的 证券账户中。此次股份过户不会造成公司股本总额、股份性质的变化，也不会对公司治理结构及持续经 营产生影响。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603121 证券简称：华培动力 公告编号：2025-036 上海华培数能科技（集团）股份有限公司 第三届董事会第十八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 上海华培数能科技（集团）股份有限公司（以下简称"公司"）第三届董事会第十八次会议于2025年9月 17日（星期三）在上海市青浦区崧秀路218号以现场结合通讯的方式召开。会议通知已于2025年9月12日 通过邮件的方式送达各位董事。本次会议由公司董事长吴怀磊先生主持，应出席董事9人，实际出席董 事9人。公司高级管理人员列席了会议。本次会议的召开符合《公司法》和《公司章程》及其他有关法 律法规的规定。 二、董事会会议审议情况 （一）审议通过了《关于以集中竞价交易方式回购公司股份的议案》 基于对公司未来发展的信心和对公司价值的认可，为建立完善的公司长效激励机制，充分调动公司员工 的积极性，有效地将股东利益、公司利益和员工个人利益紧密结合在一起，促进公司健康可持续发展， 在 ...

2025.09. 18 本文字数：1414，阅读时长大约2分钟 作者 | 第一财经 安卓 中国平安持续多年的长期服务计划，近日又完成了2025年公司股票的购买。公告显示，此次共购得H股股票7461.5万股，成交金额38.75亿元（含费 用），共约8.3万名员工参与，其中包括执行董事马明哲、谢永林在内的十多位董监高。 第一财经根据公告统计，自推出长期服务计划的7年以来，中国平安（601318.SH；02318.HK）已累计有48.68万人次参与其中，累计参与资金总额 近288亿元，共购得A股3.51亿股、H股1.82亿股。 2025年度长期服务计划完成购股 9月17日晚间，中国平安公告称，该公司2025年度长期服务计划已通过二级市场完成购股，共购得本公司H股股票7461.5万股，占总股本的比例为 0.412%，成交金额合计人民币38.75亿元（含费用），成交均价约为人民币51.87元/股。 公告称，上述购股资金均来源于员工应付薪酬额度，自愿参与2025年度长期服务计划的核心人才合计共83024人。 本次购股后，董事、监事、高级管理人员在长期服务计划中的持股比例为2.52%，其他员工持股比例为97.48%。 中国 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603121 证券简称：华培动力 公告编号：2025-037 上海华培数能科技（集团） 股份有限公司关于以集中竞价 交易方式回购股份的预案 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 回购股份金额：不低于人民币1,000万元（含），不高于人民币2,000万元（含） ● 回购股份资金来源：自有资金或自筹资金 ● 回购股份用途：本次回购的股份拟全部用于上海华培数能科技（集团）股份有限公司（以下简称"公 司"）股权激励及/或员工持股计划。公司如未能在股份回购实施完成之后36个月内使用完毕已回购的股 份，尚未使用的已回购股份将予以注销； ● 回购股份价格：不超过人民币27.42元/股（含），该价格不高于公司董事会通过回购股份决议前30个 交易日公司股票交易均价的150%； ● 回购股份方式：拟通过上海证券交易系统以集中竞价交易的方式进行股份回购； ● 回购股份期限：自公司董事会审议通过本次回购股份方案之日起12个月内； ● 相关股东是否存在减持计划 ...

Core Viewpoint - The company is focusing on its core business of AGV intelligent logistics robots and plans to expand its market presence, particularly in emerging markets like Southeast Asia and India, while maintaining strong cost control and optimizing production processes [1][2]. Group 1: Business Operations - The company specializes in AGV intelligent logistics robots, offering customized R&D and production capabilities to meet diverse industry needs [1]. - The order situation remains stable, with business levels comparable to the previous year, and delivery times vary based on product customization, ranging from 2 months for small equipment to over 6 months for large machinery [2]. - The company employs a project-based and digital management approach to monitor and control product quality and costs throughout the sales and production processes [2]. Group 2: Financial Performance - The net profit growth in the semi-annual report is attributed to optimized sales structure, increased R&D investment, lean management practices, enhanced cost control, and effective handling of exchange rate fluctuations [2]. - The company has been recognized in the all-steel radial tire forming machine sector as a national manufacturing champion, collaborating with various well-known domestic and international tire manufacturers [2]. Group 3: Future Growth and Strategy - Future revenue growth is expected to come from deepening engagement in the tire equipment industry, enhancing R&D innovation, and introducing new technologies to meet customer demands [2]. - The company plans to leverage its brand influence and maintain its competitive edge by providing high-quality products and services, with potential for equipment offerings in other sectors through production chain modifications [2]. Group 4: Market and Investor Relations - The company is committed to enhancing performance through core business focus and effective investor relations management, including reasonable profit distribution policies [3]. - Stock buyback initiatives were undertaken in 2021, with plans for employee stock ownership programs in 2023 and 2025 [3].

Core Viewpoint - Century Huatong Group announced the completion of the second lock-up period for its 2022 employee stock ownership plan, allowing 27 participants to unlock 32.207 million shares, valued at over 635 million yuan, based on the closing price on September 16 [1][2]. Group 1: Employee Stock Ownership Plan - The employee stock ownership plan was approved in September 2022, with the company repurchasing 97.43412 million shares, accounting for 1.31% of the total share capital, to fund the plan [2]. - The plan has a duration of 60 months, with shares being unlocked in phases, and the second unlock period occurring after 36 months [2]. Group 2: Performance Assessment Criteria - The core of the unlock conditions is based on performance assessment, requiring either a revenue growth of at least 20% from 2021 to 2024 or a net profit growth of at least 900% [3][4]. - Century Huatong achieved a revenue of 22.62 billion yuan in 2024, representing a 50.01% increase from 2021, surpassing the 20% threshold [4]. Group 3: Financial Performance - Century Huatong's revenue for 2024 reached 22.62 billion yuan, with a significant year-on-year increase of 70.27%, and net profit rose to 1.213 billion yuan, marking a 131.51% increase [5]. - In the first half of 2025, the company reported a revenue of 17.21 billion yuan, up 85.5%, and net profit increased to 2.656 billion yuan, reflecting a 129.33% growth [5]. Group 4: Business Segment Performance - The gaming segment was a key driver of growth, generating 16.433 billion yuan in revenue, accounting for 95.50% of total revenue, with a gross margin improvement to 72.25% [8]. - Century Huatong ranked second in the "2025 H1 China Mobile Game Publisher Revenue TOP80" list, surpassing traditional giants like NetEase [8]. Group 5: Market Recognition - The company's stock price increased from a low of 2.99 yuan to a high of 20.76 yuan, nearly a sevenfold increase, with a market capitalization exceeding 140 billion yuan, making it the top gaming company in the A-share market [9].

Core Viewpoint - The company has implemented a stock incentive plan for 2025, ensuring compliance with relevant regulations and confirming no insider trading occurred during the review period [1][5]. Group 1: Stock Incentive Plan - The company held a board meeting on August 28, 2025, to approve the draft of the 2025 stock incentive plan [1]. - The plan was developed in accordance with the "Management Measures for Equity Incentives of Listed Companies" and other relevant regulations [2]. - The company has taken necessary confidentiality measures and registered insiders related to the incentive plan [2]. Group 2: Self-Examination of Insider Trading - A self-examination was conducted regarding the trading activities of insiders and initial grant recipients during the six months prior to the public disclosure of the incentive plan [2][3]. - During the self-examination period, 135 individuals were identified as having traded the company's stock, with one insider trading before being aware of the incentive plan [3]. - The remaining 134 initial grant recipients traded based on publicly available information and were unaware of the incentive plan details [3][4]. Group 3: Conclusion of Self-Examination - The company confirmed that no insider trading or leakage of insider information occurred during the self-examination period, adhering to legal and regulatory requirements [5].

关于2025年员工持股计划第一次持有人会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 紫金矿业集团股份有限公司（以下简称"公司"）2025年员工持股计划第一次持有人会议已通过通讯表决 方式召开，出席会议的员工持股计划持有人代表公司2025年员工持股计划有表决权的份额为6,431.6万 份，占本次员工持股计划总份额的100%。本次会议的召集、召开和表决程序符合相关法律法规、规范 性文件的规定，会议审议通过以下事项： 证券代码：601899 股票简称：紫金矿业编号：临2025-075 紫金矿业集团股份有限公司 （1）负责召集持有人会议，执行持有人会议的决议； （2）代表全体持有人进行员工持股计划的日常管理及监督； （3）代表全体持有人行使员工持股计划所持有股份的股东权利； （4）负责与公司董事会、股东会的协调事宜； （5）管理员工持股计划利益和权益分配； 一、审议通过《关于设立公司2025年员工持股计划管理委员会的议案》 为保证公司2025年员工持股计划的顺利进行，保障持有人的合法权益，提高本次员工持股计划日常管理 ...

Core Viewpoint - Heng Rui Medicine (600276) has announced a 2025 A-share employee stock ownership plan aimed at establishing a profit-sharing mechanism among the company, shareholders, and employees to enhance employee motivation, creativity, cohesion, and overall competitiveness, thereby promoting the company's long-term and sustainable development [1] Summary by Relevant Sections - The employee stock ownership plan involves the repurchase of up to 14 million A-shares, accounting for approximately 0.21% of the company's total share capital as of the announcement date [1] - The repurchase price is set at 30.95 yuan per share, with the final number of shares held under the plan to be determined based on actual execution [1] - The total number of employees participating in the plan is expected to be no more than 1,316 (excluding reserved shares), with a maximum of 9 individuals from the board (excluding independent directors), supervisors, and senior management [1]

Core Viewpoint - Heng Rui Medicine (01276) has announced a 2025 A-share employee stock ownership plan aimed at establishing a profit-sharing mechanism among the company, shareholders, and employees to enhance employee motivation, creativity, cohesion, and overall company competitiveness, promoting long-term and sustainable development [1] Summary by Relevant Sections - Employee Stock Ownership Plan Details - The plan involves the acquisition of up to 14 million A-shares (including reserved shares), accounting for approximately 0.21% of the company's total share capital as of the announcement date [1] - The acquisition price is set at 30.95 yuan per share, with the final number of shares held under the plan to be determined based on actual execution [1] - Participation and Eligibility - The total number of employees participating in the plan is expected to be no more than 1,316 (excluding reserved shares) [1] - Among the participants, the number of company directors (excluding independent directors), supervisors, and senior management is limited to no more than 9 (excluding reserved shares), with the final number of participants and subscription details to be confirmed based on actual employee contributions [1]